Taiwan Reaffirms Stance Amid US Warning Following Beijing Summit Traders See Rising Odds of Inflation Approaching 5 This Year Prediction Markets Indicate Pelagos Insurance Capital CEO Dan Burrows Discusses LongTerm Vision Behind Company Rebrand HubSpot HUBS Q1 2026 Earnings Surprise EPS 272 Up Significant Tesla Expands Full SelfDriving Supervised to China as Domestic EV Rivals Accelerate Autonomous Tech BuzzBallz 99p Shot Faces Criticism from Alcohol Charities Over Youth Appeal NASA Selects Lunar Outpost to Deliver Crewed Lunar Terrain Vehicle for Artemis Moon Missions Amazon UK Director Challenges Blame on Youth Unemployment Points to Education System Gap Investors Flock to HALO Stocks A New ETF Captures the AIProof Theme Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Brief CIFR Q1 2026 Earnings EPS Misses Estimates as Crypto Mining Headwinds Mount ZGN Q4 2025 Earnings Strong EPS Beat Amid Revenue Discrepancies Ready Capital Corporation RC Q1 2026 Earnings Deep EPS Miss as Net Loss Exceeds Expectations NextNRG Inc NXXT Q1 2026 Earnings Narrowing Loss Beats Estimates Shares Surge Bristow Group Inc VTOL Q1 2026 Earnings EPS Misses Estimates Stock Declines ADAMH Q1 2026 Earnings Earnings Surge Past Estimates with 75 Surprise Laird Superfood LSF Surges 785 Key Levels and Market Dynamics Stellar V Capital Corp Unit SVCCU Holds Steady Key Support and Resistance Define the Next Move Best Buy BBY Bounces 258 as Retail Sector Finds Its Footing Shattuck Labs STTK Sees Modest Gain Consolidates Near Key Support Level FTAIN Preferred Shares FTAIN Hold Steady Near Key Support Levels JetBlue JBLU Q1 2026 Earnings Miss EPS 087 vs 072 Expected Court Rulings Reshape House Race Democrats Odds Slip as Redistricting Battles Intensify BNY Muni Fund DSM Stock Down 131 Support Test at 573 20260515 Oportun OPRT Reports Strong Q1 2026 Revenue NA EPS Beats Universal UHT Falls 123 Watching 3825 Support 20260515 Pershing Square IPO Bill Ackmans Hedge Fund Plans Dual Stock Listing on NYSE LXFR Q1 2026 Earnings EPS Surges Past Estimates Driving Stock Higher Design Therapeutics DSGN Declines 2 as Shares Test Key Support Levels